Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
7U54RR019397-02
Application #
6982983
Study Section
Special Emphasis Panel (ZRG1-EDC-1 (50))
Project Start
2004-08-01
Project End
2005-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
2
Fiscal Year
2004
Total Cost
$1,089,924
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Sanikommu, Srinivasa R; Clemente, Michael J; Chomczynski, Peter et al. (2018) Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL). Leuk Lymphoma 59:416-422
Nyland, Susan Bell; Krissinger, Daniel J; Clemente, Michael J et al. (2012) Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study. Leuk Res 36:581-7
Sekeres, Mikkael A; Tiu, Ramon V; Komrokji, Rami et al. (2012) Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes. Blood 120:4945-51
Bai, Fanqi; Villagra, Alejandro V; Zou, Jianxiang et al. (2012) Tipifarnib-mediated suppression of T-bet-dependent signaling pathways. Cancer Immunol Immunother 61:523-33
Sekeres, Mikkael A; O'Keefe, Christine; List, Alan F et al. (2011) Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes. Am J Hematol 86:102-3
Sekeres, Mikkael A; Maciejewski, Jaroslaw P; Erba, Harry P et al. (2011) A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia. Cancer 117:1253-61
Afable 2nd, Manuel G; Shaik, Mohammed; Sugimoto, Yuka et al. (2011) Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Haematologica 96:1269-75
Szpurka, Hadrian; Jankowska, Anna M; Makishima, Hideki et al. (2010) Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations. Leuk Res 34:969-73
Bejanyan, Nelli; Fu, Alex Z; Lazaryan, Aleksandr et al. (2010) Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia. Cancer 116:3614-20
Jasek, M; Gondek, L P; Bejanyan, N et al. (2010) TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p. Leukemia 24:216-9

Showing the most recent 10 out of 25 publications